Treatment

BEAM-302 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
This study is testing a new medicine, BEAM-302, for adults with Alpha-1 Antitrypsin Deficiency (AATD). It will check if the medicine is safe, how well it works, and find the best dose to help people with lung or liver problems caused by AATD.
For: Alpha 1-Antitrypsin Deficiency
United States · Australia · Ireland